Cite
HARVARD Citation
Bang, Y. et al. (n.d.). P-096A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress. Annals of oncology. p. . [Online].